BR100 Decreased By (-0.98%)
BR30 Decreased By (-0.58%)
KSE100 Decreased By (-0.97%)
KSE30 Decreased By (-1.07%)
AGHA 7.70 Decreased By ▼ -0.11 (-1.41%)
BECO 5.16 Decreased By ▼ -0.05 (-0.96%)
BML 56.60 Decreased By ▼ -0.90 (-1.57%)
BOP 33.82 Decreased By ▼ -0.21 (-0.62%)
CNERGY 9.95 Decreased By ▼ -0.01 (-0.1%)
CSIL 5.30 Decreased By ▼ -0.01 (-0.19%)
FCCL 53.07 Decreased By ▼ -1.63 (-2.98%)
FFL 16.58 Decreased By ▼ -0.11 (-0.66%)
FNEL 1.22 Decreased By ▼ -0.01 (-0.81%)
KEL 7.27 Decreased By ▼ -0.13 (-1.76%)
KOSM 5.73 Decreased By ▼ -0.04 (-0.69%)
LOTCHEM 29.55 Increased By ▲ 0.23 (0.78%)
MLCF 92.90 Decreased By ▼ -1.46 (-1.55%)
NBP 202.00 Decreased By ▼ -1.05 (-0.52%)
NCPL 56.84 Decreased By ▼ -0.16 (-0.28%)
NPL 66.62 Decreased By ▼ -1.08 (-1.6%)
OGDC 318.98 Increased By ▲ 3.14 (0.99%)
PACE 10.55 Decreased By ▼ -0.09 (-0.85%)
PAEL 42.31 Decreased By ▼ -0.89 (-2.06%)
PIBTL 16.39 Decreased By ▼ -0.35 (-2.09%)
PPL 218.50 Decreased By ▼ -1.28 (-0.58%)
PRL 51.20 Increased By ▲ 2.01 (4.09%)
PTC 70.00 Decreased By ▼ -0.53 (-0.75%)
SSGC 26.96 Decreased By ▼ -1.29 (-4.57%)
TBL 9.75 Decreased By ▼ -0.11 (-1.12%)
TELE 8.68 Decreased By ▼ -0.11 (-1.25%)
TPL 17.99 Decreased By ▼ -0.25 (-1.37%)
TPLP 13.44 Increased By ▲ 0.17 (1.28%)
TREET 22.55 Decreased By ▼ -0.17 (-0.75%)
TRG 59.48 Decreased By ▼ -0.66 (-1.1%)
World

Australia reports first death from blood clots 'likely' linked to AstraZeneca vaccine

  • "In the absence of an alternative cause for the clinical syndrome, VSIG believed that a causative link to vaccination should be assumed at this time," the TGA said.
  • The TGA said her case had been complicated by underlying medical conditions, including diabetes, "as well as some atypical features."
Published Updated
By

SYDNEY: Australia on Friday reported its first death from blood clots linked to the AstraZeneca COVID-19 vaccine after the country's regulator said a 48-year-old woman's fatality was "likely" linked to the shot.

Australia's Vaccine Safety Investigation Group (VSIG), which held a late meetig on Friday, concluded the New South Wales woman's death was likely linked to the vaccination, the Therapeutic Goods Administration said in a statement.

"In the absence of an alternative cause for the clinical syndrome, VSIG believed that a causative link to vaccination should be assumed at this time," the TGA said.

This was the third instance of the rare blood clots linked to the vaccine in Australia with the other two patients recovering well, the TGA added.

The 48-year-old woman died four days after receiving the vaccination.

The TGA said her case had been complicated by underlying medical conditions, including diabetes, "as well as some atypical features."

Comments

Comments are closed for this article.